Search

David Jones Pickar

from Chevy Chase, MD
Age ~76

David Pickar Phones & Addresses

  • 4915 Dorset Ave, Chevy Chase, MD 20815 (301) 907-4881 (301) 387-8286
  • Bethesda, MD
  • Virginia Beach, VA
  • Lewes, DE
  • 2936 28Th St NW, Washington, DC 20008 (202) 387-8286
  • 6500 Seven Locks Rd, Cabin John, MD 20818 (301) 263-1313
  • Richmond, VA

Work

Company: Terran biosciences May 2019 to 2020 Position: Chief scientific officer

Education

School / High School: Yale University 1973

Skills

Microsoft Word • Microsoft Office • Powerpoint • Microsoft Excel • Public Speaking • Clinical Research • Leadership • Strategic Planning

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Psychiatry, 1978

Interests

Collecting Antiques • Home Improvement • Reading • Gourmet Cooking • The Arts • Home Decoration • Cooking • Gardening • Electronics • Crafts • Music • Family Values • Movies • Collecting • Christianity • Kids • Parenting • Travel • Investing

Industries

Pharmaceuticals

Specialities

Neuropsychiatry (Psychiatry)

Professional Records

Medicine Doctors

David Pickar Photo 1

Dr. David Pickar, Chevy Chase MD - MD (Doctor of Medicine)

View page
Specialties:
Neuropsychiatry (Psychiatry)
Address:
4915 Dorset Ave Suite 220, Chevy Chase, MD 20815
(301) 263-1313 (Phone), (301) 263-1315 (Fax)

6500 Seven Locks Rd Suite 220, Cabin John, MD 20818
(301) 263-1313 (Phone), (301) 229-1815 (Fax)
Certifications:
Psychiatry, 1978
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Yale University
Graduated: 1973
David Pickar Photo 2

David Pickar

View page
Specialties:
Psychiatry
Work:
Gabriel Sciences LLC
4915 Dorset Ave, Chevy Chase, MD 20815
(301) 263-1313 (phone), (301) 263-1315 (fax)
Education:
Medical School
Yale University School of Medicine
Graduated: 1973
Conditions:
Anxiety Phobic Disorders
Attention Deficit Disorder (ADD)
Bipolar Disorder
Depressive Disorders
Obsessive-Compulsive Disorder (OCD)
Languages:
English
Description:
Dr. Pickar graduated from the Yale University School of Medicine in 1973. He works in Chevy Chase, MD and specializes in Psychiatry.
David Pickar Photo 3

David Pickar, Bethesda MD

View page
Specialties:
Psychiatry
Geriatric Psychiatry
Work:
National Institutes of Health
9000 Rockville Pike, Bethesda, MD 20892
Education:
Yale University (1973)

License Records

David Pickar

Address:
4915 Dorset, Chevy Chase, MD
Phone:
(240) 463-6722
License #:
3822 - Active
Category:
Health Care
Issued Date:
May 16, 2016
Effective Date:
May 16, 2016
Expiration Date:
May 15, 2018
Type:
Medical Doctor Expert Witness Certificate

Resumes

Resumes

David Pickar Photo 4

President

View page
Location:
4915 Dorset Ave, Chevy Chase, MD 20815
Industry:
Pharmaceuticals
Work:
Terran Biosciences May 2019 - 2020
Chief Scientific Officer

Terran Biosciences May 2019 - 2020
Chief Science Officer

Fda Jun 2014 - Jun 2018
Psychiatry Advisory Committee

Johns Hopkins School of Medicine Jun 2014 - Jun 2018
Adjunct Professor of Psychiatry

National Institute of Mental Health (Nimh) 2002 - 2008
Grants Awarded
Education:
Yale University School of Medicine 1974 - 1977
University of Kentucky 1973 - 1974
Yale University School of Medicine 1969 - 1973
Doctor of Medicine, Doctorates, Bachelors, Medicine
Rutgers University–New Brunswick 1965 - 1969
Bachelors, Bachelor of Arts
Skills:
Microsoft Word
Microsoft Office
Powerpoint
Microsoft Excel
Public Speaking
Clinical Research
Leadership
Strategic Planning
Interests:
Collecting Antiques
Home Improvement
Reading
Gourmet Cooking
The Arts
Home Decoration
Cooking
Gardening
Electronics
Crafts
Music
Family Values
Movies
Collecting
Christianity
Kids
Parenting
Travel
Investing
Languages:
English
Certifications:
Diplomate
Examiner For Oral Examination
Examiner

Business Records

Name / Title
Company / Classification
Phones & Addresses
David Pickar
David Pickar MD
Psychiatrist
4915 Dorset Ave, Chevy Chase, MD 20815
(301) 263-1313
David Pickar
Medical Doctor
Gabriel Sciences LLC
Commercial Physical Research · Pharmacuetical Development Company
6500 7 Lck Rd, Cabin John, MD 20818
4915 Dorset Ave, Bethesda, MD 20815
(301) 263-1313

Publications

Amazon

Atypical Antipsychotics In The Treatment Of Schizophrenic Patients (Uni-Med Science)

Atypical Antipsychotics in the Treatment of Schizophrenic Patients (Uni-Med Science)

View page
Author

Dieter Naber, Martin Lambert, Michael Krausz, Christian Haasen, David Pickar

Binding

Hardcover

Pages

352

Publisher

UNI-MED Verlag AG

ISBN #

3895995282

EAN Code

9783895995286

ISBN #

2

The Psychiatric Clinics Of North America Vol. 6 No. 3 September 1983: Endorphins

The Psychiatric Clinics of North America Vol. 6 No. 3 September 1983: Endorphins

View page
Author

Samuel Craig and David Pickar Risch

Binding

Hardcover

Publisher

W.B. Saunders

ISBN #

1

The Psychiatric Clinics of North America (Endorphins)

View page
Author

Samuel Craig Risch and David Pickar

Binding

Unknown Binding

Publisher

Saunders

ISBN #

3

Us Patents

System For Pharmacogenetics Of Adverse Drug Events

View page
US Patent:
20030104453, Jun 5, 2003
Filed:
Nov 6, 2002
Appl. No.:
10/288338
Inventors:
David Pickar - Chevy Chase MD, US
Jack Hidary - New York NY, US
Elizabeth Gray - Cabin John MD, US
International Classification:
C12Q001/68
G06F017/60
G06F019/00
G01N033/48
G01N033/50
US Classification:
435/006000, 702/020000, 705/003000
Abstract:
The present invention relates to computer systems and methods of analyzing an association between genotypes and adverse drug events for providing personalized medical advice and pharmacogenomic therapy based on patients personal genetic make-up. According to one embodiment, the present invention may create a patient interface for pharmacogenetic studies targeting adverse events and to a database system which allows for application of genetic risk factors for a specific adverse event to a population who might be candidates for specific drug treatment. According to another embodiment, the present invention may provide assistance and guidance in managing and minimizing risk of adverse events utilizing a pharmacogenetic process.

Pharmacogenomics-Based Clinical Trial Design Recommendation And Management System And Method

View page
US Patent:
20030108938, Jun 12, 2003
Filed:
Nov 6, 2002
Appl. No.:
10/288336
Inventors:
David Pickar - Chevy Chase MD, US
Jack Hidary - New York NY, US
Elizabeth Gray - Cabin John MD, US
International Classification:
G06F017/60
C12Q001/68
G06F019/00
G01N033/48
G01N033/50
US Classification:
435/006000, 702/020000, 705/003000
Abstract:
The present invention relates to computer systems and methods for clinical trials for linking biological information including genomic and proteomic information to the conduct and success of the clinical trial process for therapeutic agents. In particular, the present invention relates to computer systems and methods of analyzing genotypes, clinical phenotypes, and clinical trial requirements for providing recommendations for conduct of various phases of clinical trial process. The system may include a genotype database, a clinical database, clinical trial requirements database, an analytical computer, a recommended trial database, a blood bank, and sequencing machines.

Novel Antipsychotic Combination Therapies And Compositions Useful Therein

View page
US Patent:
20040127489, Jul 1, 2004
Filed:
Jul 28, 2003
Appl. No.:
10/629123
Inventors:
David Pickar - Chevy Chase MD, US
Torgny Svensson - Lidingo, SE
Marie-Louise Wadenberg - Haninge, SE
International Classification:
A61K031/5513
A61K031/551
A61K031/4745
A61K031/519
US Classification:
514/220000, 514/283000, 514/259410
Abstract:
The present invention provides novel antipsychotic therapies and compositions useful therein and provides methods for identifying new candidate molecules for the treatment of psychosis based on the proportional binding affinities for adrenergic and Ddopamine receptors.

Antipsychotic Combination Therapies And Compositions Of An Alpha-2 Adrenergic Receptor Antagonist And An Atypical Antipsychotic Neuroleptic

View page
US Patent:
20060281735, Dec 14, 2006
Filed:
Apr 17, 2006
Appl. No.:
11/405360
Inventors:
David Pickar - Chevy Chase MD, US
Torgny Svensson - Lidingo, SE
Marie-Louise Wadenberg - Stockholm, SE
International Classification:
A61K 31/551
A61K 31/4178
US Classification:
514220000, 514402000
Abstract:
The present invention provides novel antipsychotic therapies and compositions useful therein and provides methods for identifying new candidate molecules for the treatment of psychosis based on the proportional binding affinities for αadrenergic and Ddopamine receptors.

Antipsychotic Composition And Method Of Treatment

View page
US Patent:
56631677, Sep 2, 1997
Filed:
Jun 7, 1995
Appl. No.:
8/479039
Inventors:
David Pickar - Bethesda MD
Robert E. Litman - Bethesda MD
William Z. Potter - Washington DC
Assignee:
The United States of America as represented by the Department of Health
and Human Services - Washington DC
International Classification:
A61K 3154
US Classification:
5142258
Abstract:
A method for treating a serious psychotic mental illness includes the step of administering to a patient in need of such treatment a combination of (i) an. alpha. sub. 2 -adrenergic receptor antagonist and (ii) a D. sub. 2 dopamine receptor antagonist. A pharmaceutical composition useful in the novel method includes an effective amount of the combination of the foregoing two ingredients together with a pharmaceutically acceptable carrier.

Antipsychotic Composition And Method Of Treatment

View page
US Patent:
54929075, Feb 20, 1996
Filed:
Dec 9, 1992
Appl. No.:
7/987728
Inventors:
David Pickar - Bethesda MD
Robert E. Litman - Bethesda MD
William Z. Potter - Washington DC
Assignee:
The United States of America as represented by the Department of Health
& Human Services - Washington DC
International Classification:
A61K 3154
US Classification:
5142258
Abstract:
A method for treating a serious psychotic mental illness includes the step of administering to a patient in need of such treatment a combination of (i) an. alpha. sub. 2 -adrenergic receptor antagonist and (ii) a D. sub. 2 dopamine receptor antagonist, A pharmaceutical composition useful in the novel method includes an effective amount of the combination of the foregoing two ingredients together with a pharmaceutically acceptable carrier.
David Jones Pickar from Chevy Chase, MD, age ~76 Get Report